Advanced intraocular retinoblastoma: evolving criteria for group E disease

Ahad Sedaghat; Vishal Raval; Renbing Jia; Xianqun Fan; Arun D Singh

doi:10.1016/j.jcjo.2024.03.005

Advanced intraocular retinoblastoma: evolving criteria for group E disease

Can J Ophthalmol. 2024 Apr 27:S0008-4182(24)00068-1. doi: 10.1016/j.jcjo.2024.03.005. Online ahead of print.

Authors

Ahad Sedaghat¹, Vishal Raval², Renbing Jia³, Xianqun Fan³, Arun D Singh⁴

Affiliations

¹ Ophthalmic Oncology, Cole Eye Institute, Cleveland Clinic, Cleveland, OH.
² Operation Eyesight Universal Institute for Eye Cancer, LV Prasad Eye Institute, Hyderabad, India.
³ Department of Ophthalmology, Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
⁴ Ophthalmic Oncology, Cole Eye Institute, Cleveland Clinic, Cleveland, OH. Electronic address: SINGHA@ccf.org.

PMID: 38688458
DOI: 10.1016/j.jcjo.2024.03.005

Abstract

With evolving criteria for classifying intraocular retinoblastoma (RB) from International Intraocular Retinoblastoma Classification (IIRC, 2005) to International Classification of Retinoblastoma (ICRB, 2006), there have been changes in the inclusion criteria for groups E eyes that have not been widely recognized. This brief review highlights issues with the current classification systems (ICRB and IIRC) and layouts a theoretical framework arguing for merging of 2 existing classifications into 1 and subdividing the expanded group E RB, thereby preserving the possibility to reanalyze existing published data.

Publication types

Letter